Abstract
Few elderly patients have been included in randomized trials assessing recombinant tissue plasminogen activator (rtPA) in stroke. In North America, intravenous thrombolysis is allowed in these patients; however, the European Medicines Agency does not recommend rtPA for the treatment of stroke in patients over 80 years of age. The influence of age on outcome following stroke-unit care and rehabilitation also remains controversial. In the absence of randomized trials, the efficacy of thrombolysis in elderly patients is difficult to measure. The majority of rtPA cohort studies demonstrate that patients over 80 years of age have lower rates of positive outcomes following treatment than younger patients. These studies are, however, reassuring with regard to the risk of symptomatic intracerebral hemorrhage and death, and suggest that rtPA can be safely administered to carefully selected elderly patients within 3 h of the onset of stroke. Further randomized studies will lead to more-accurate conclusions about the efficacy and safety of rtPA in the elderly subgroup. Admission to a stroke unit rather than to a general ward and early rehabilitation are justified in elderly patients. In this article, we review the literature regarding the effect of thrombolysis, stroke-unit care, and rehabilitation in patients over 80 years of age with stroke.
Key Points
-
Elderly patients constitute 30% of all patients with ischemic stroke; however, such individuals are at risk of receiving suboptimal care
-
Patients aged 80 years or over with stroke have a substantially higher mortality risk than younger patients and are less likely to make a favorable recovery
-
Intravenous thrombolysis, using recombinant tissue plasminogen activator, is safe and potentially effective in patients aged 80 years or over with stroke; however, data from randomized placebo-controlled studies are lacking in this subgroup
-
Admission to a stroke unit is beneficial across all age ranges, and is associated with reductions in the probabilities of death, disability, and institutionalization
-
Rehabilitation might be more challenging in elderly patients with stroke than in younger individuals, but no evidence exists to suggest that age alone should influence decisions on eligibility for rehabilitation
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Qureshi, A. I. et al. Thrombolysis for ischemic stroke in the United States: data from national hospital discharge survey 1999–2001. Neurosurgery 57, 647–654 (2005).
Ringelstein, E. B. et al. European stroke facilities survey: the German and Austrian perspective. Cerebrovasc. Dis. 27, 138–145 (2009).
Hacke, W. et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet 352, 1245–1251 (1998).
Hacke, W. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317–1329 (2008).
Bonita, R., Solomon, N. & Broad, J. B. Prevalence of stroke and stroke-related disability: estimates from the Auckland stroke studies. Stroke 28, 1898–1902 (1997).
Di Carlo, A. et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 34, 1114–1119 (2003).
Marini, C. et al. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology 62, 77–81 (2004).
Hemphill, J. C. Jr & Lyden, P. Stroke thrombolysis in the elderly: risk or benefit? Neurology 65, 1690–1691 (2005).
Dennis, M. S. et al. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 24, 796–800 (1993).
Nakayama, H., Jorgensen, H. S., Raaschou, H. O. & Olsen, T. S. The influence of age on stroke outcome. The Copenhagen Stroke Study. Stroke 25, 808–813 (1994).
Lai, S. M., Alter, M., Friday, G. & Sobel, E. Prognosis for survival after an initial stroke. Stroke 26, 2011–2015 (1995).
Kammersgaard, L. P. et al. Short- and long-term prognosis for very old stroke patients. The Copenhagen Stroke Study. Age Ageing 33, 149–154 (2004).
Sharma, J. C., Fletcher, S. & Vassallo, M. Stroke in the elderly: higher acute and 3-month mortality-an explanation. Cerebrovasc. Dis. 9, 2–9 (1999).
Di Carlo, A. et al. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome. A European perspective. European BIOMED Study of Stroke Care Group. Stroke 30, 2313–2319 (1999).
Olindo, S. et al. Acute stroke in the very elderly: epidemiological features, stroke subtypes, management, and outcome in Martinique, French West Indies. Stroke 34, 1593–1597 (2003).
Kaste, M., Palomäki, H. & Sarna, S. Where and how should elderly stroke patients be treated? A randomized trial. Stroke 26, 249–253 (1995).
Ridker, P. M. & Hennekens, C. H. Age and thrombolytic therapy. Circulation 94, 1807–1808 (1996).
Gurwitz, J. H. et al. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Ann. Intern. Med. 129, 597–604 (1998).
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 28, 2109–2118 (1997).
Larrue, V., von Kummer, R., del Zoppo, G. & Bluhmki, E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28, 957–960 (1997).
Larrue, V., von Kummer, R., Müller, A. & Bluhmki, E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator. A secondary analysis of the European–Australasian Acute Stroke Study (ECASS II). Stroke 32, 438–441 (2001).
Derex, L. et al. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator. J. Neurol. Neurosurg. Psychiatry 76, 70–75 (2005).
Tanne, D. et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 105, 1679–1685 (2002).
Heuschmann, P. U. et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA 292, 1831–1838 (2004).
Neumann-Haefelin, T. et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 37, 2463–2466 (2006).
Sloan, M. A. et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II pilot and randomised clinical trial combined experience. Neurology 45, 649–658 (1995).
Tanne, D. et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA Stroke Survey experience. Stroke 31, 370–375 (2000).
Simon, J. E, Sandler, D. L., Pexman, J. H., Hill, M. D. & Buchan, A. M., for the Calgary Stroke Programme. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? The Calgary experience. Age Ageing 33, 143–149 (2004).
Berrouschot, J. et al. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients. Stroke 36, 2421–2425 (2005).
Engelter, S. T. et al. Thrombolysis in stroke patients aged 80 years and older. Swiss survey of IV thrombolysis. Neurology 65, 1795–1798 (2005).
Mouradian, M. S. et al. Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients. J. Neurol. Neurosurg. Psychiatry 76, 1234–1237 (2005).
Chen, C. I. et al. Intravenous tPA for very old stroke patients. Eur. Neurol. 54, 140–144 (2005).
Van Oostenbrugge, R. J., Hupperts, R. M. & Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre. J. Neurol. Neurosurg. Psychiatry 77, 375–377 (2006).
Sylaja, P. N., Cote, R., Buchan, A. M. & Hill, M. D. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol. Neurosurg. Psychiatry. 77, 826–829 (2006).
Jauss, M., Allendörfer, J., Stolz, E., Schütz, H. J. & Misselwitz, B. Treatment results of stroke patients aged >80 years receiving intravenous rt-PA. Cerebrovasc. Dis. 24, 305–306 (2007).
Ringleb, P. A. et al. Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome. J. Neurol. Neurosurg. Psychiatry 78, 690–693 (2007).
Uyttenboogaart, M., Schrijvers, E. M., Vroomen, P. C., De Keyser, J. & Luijckx, G. J. Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience. Age Ageing 36, 577–579 (2007).
Meseguer, E. et al. Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review. Age Ageing 37, 107–111 (2008).
Gómez-Choco, M. et al. The response to IV rt-PA in very old stroke patients. Eur. J. Neurol. 15, 253–256 (2008).
Toni, D. et al. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc. Dis. 25, 129–135 (2008).
The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 28, 2119–2125 (1997).
Engelter, S. T., Bonati, L. H. & Lyrer, P. A. Intravenous thrombolysis in stroke patients of ≥80 versus <80 years of age—a systematic review across cohort studies. Age Ageing 35, 572–580 (2006).
Derex, L. & Nighoghossian, N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J. Neurol. Neurosurg. Psychiatry 79, 1093–1099 (2008).
Tong, D. C., Adami, A., Moseley, M. E. & Marks, M. P. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 31, 2378–2384 (2000).
Tong, D. C., Adami, A., Moseley, M. E. & Marks, M. P. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging. Arch. Neurol. 58, 587–593 (2001).
Selim, M. et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 33, 2047–2052 (2002).
Albers, G. W. et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann. Neurol. 60, 508–517 (2006).
Lansberg, M. G. et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 38, 2275–2278 (2007).
Latour, L. L., Kang, D. W., Ezzedine, M. A., Chalela, J. A. & Warach, S. Early blood–brain barrier disruption in human focal brain ischemia. Ann. Neurol. 56, 468–477 (2004).
Thomalla, G. et al. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 37, 852–858 (2006).
Kim, D. et al. Intra-arterial thrombolysis for acute stroke in patients 80 and older. A comparison of results in patients younger than 80 years. AJNR Am. J. Neuroradiol. 28, 159–163 (2007).
European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc. Dis. 25, 457–507 (2008).
Rudd, A. G., Hoffman, A., Down, C., Pearson, M. & Lowe, D. Access to stroke care in England, Wales and Northern Ireland: the effect of age, gender and weekend admission. Age Ageing 36, 247–255 (2007).
Langhorne, P., Williams, B. O., Gilchrist, W. & Howie, K: Do stroke units save lives? Lancet 342, 395–398 (1993).
Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews, Issue 4. Art. No.:CD000197.doi:10.1002/14651858.CD000197.pub2 (2007).
Candelise, L. et al. Stroke-unit care for acute stroke patients: an observational follow-up study. Lancet 369, 299–305 (2007).
Garraway, W. M., Whisnant, J. P. & Drury, I. The changing pattern of survival following stroke. Stroke 14, 699–703 (1983).
Kalra, L. Does age affect benefits of stroke unit rehabilitation? Stroke 25, 346–351 (1994).
Bagg, S., Pombo, A. P. & Hopman, W. M. Effect of age on functional outcomes after stroke rehabilitation. Stroke 33, 179–185 (2002).
Lo, R. S. et al. Handicap and its determinants of change in stroke survivors. One-year follow-up study. Stroke 39, 148–153 (2008).
Kong, K. H., Chua, K. S. & Tow, A. P. Clinical characteristics and functional outcome of stroke patients 75 years old and older. Arch. Phys. Med. Rehabil. 79, 1535–1539 (1998).
Ergeletzis, D., Kevorkian, C. G. & Rintala, D. Rehabilitation of the older stroke patient: functional outcome and comparison with younger patients. Am. J. Phys. Med. Rehabil. 81, 881–889 (2002).
Luk, J. K., Cheung, R. T., Ho, S. L. & Li, L. Does age predict outcome in stroke rehabilitation? A study of 878 Chinese subjects. Cerebrovasc. Dis. 21, 229–234 (2006).
Bhalla, A., Grieve, R., Tilling, K., Rudd, A. G. & Wolfe, C. D. Older stroke patients in Europe: stroke care and determinants of outcome. Age Ageing 33, 618–624 (2004).
Saposnik, G. et al. Stroke outcome in those over 80: a multicenter cohort study across Canada. Stroke 39, 2310–2317 (2008).
Rabadi, M. H., Rabadi, F. M., Edelstein, L. & Peterson, M. Cognitively impaired stroke patients do benefit from admission to an acute rehabilitation unit. Arch. Phys. Med. Rehabil. 89, 441–448 (2008).
Vatankhah, B. et al. Thrombolysis for stroke in the elderly. J. Thromb. Thrombolysis 20, 5–10 (2005).
Ford, G. A. Thrombolysis for stroke in the over 80s. Age Ageing 33, 95–97 (2004).
Acknowledgements
The authors would like to thank Miss Frédérique Groga-Bada for her help in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Derex, L., Nighoghossian, N. Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients. Nat Rev Neurol 5, 506–511 (2009). https://doi.org/10.1038/nrneurol.2009.127
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.127
This article is cited by
-
Acute stroke treatment and outcome in the oldest old (90 years and older) at a tertiary care medical centre in Germany-a retrospective study showing safety and efficacy in this particular patient population
BMC Geriatrics (2021)
-
Impact of leukoaraiosis on parenchymal hemorrhage in elderly patients treated with thrombolysis
Neuroradiology (2016)
-
Quality of Life After Off-Label Thrombolysis for Ischemic Stroke in Elderly Patients
Drugs & Aging (2015)
-
Safety and Efficacy of Thrombolysis with Intravenous Alteplase in Older Stroke Patients
Drugs & Aging (2013)
-
Ergebnisse und Prädiktoren der geriatrischen Frührehabilitation im Akutkrankenhaus
Zeitschrift für Gerontologie und Geriatrie (2012)